Walpar Nutritions IPO: GMP, Price, Dates, Issue Size 

Rate this post

Walpar Nutritions IPO is all set to make its debut on 30th June 21 with 5.13 Cr manufactures different types of Nutraceuticals, Ayurvedic, Cosmeceuticals, Sexual Wellness, and food supplement products. 

Walpar Nutritions IPO – overview 

IPO Dates  30th June – 5th  July 2021 
IPO Price  INR 55 per share  
Fresh issue  – 
Offer For Sale  Nil 
Total IPO size  1,200,000 shares (INR 6.60 crore) 
Minimum bid (lot size)  2000 shares 
Face Value   INR 10 per share  
Retail Allocation  50%  
Listing On  NSE Emerge 
Ducol Organics IPO: GMP, Price, Dates, Issue size

Walpar Nutritions IPO – Tentative Dates           

IPO Offer Opening Date  27 July 2021 
IPO Closing Date  30 July 2021 
Finalization of Basis of Allotment  4 Aug 2021 
Initiation of refunds  5 Aug 2021 
Transfer of shares to demat accounts  6 Aug 2021 
IPO Listing Date  9 Aug 2021 
Opening Price on NSE SME  Coming soon  
Closing Price on NSE SME  Coming soon 
Ducol Organics IPO: GMP, Price, Dates, Issue size

Company Overview    

Incorporated in 2009, Walpar Nutritions manufactures different types of Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness, and food supplement products.

The company has a manufacturing facility in Gandhinagar with an installed manufacturing capacity of 23 lakhs tablet/month, 12.50 lakhs capsules/month, 1.50 lakhs oral liquids/month, and 2 lakhs sachets/month. 

Industry Overview    

India is the largest provider of generic drugs globally. Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US and 25% of all medicine in the UK. India enjoys an important position in the global pharmaceuticals sector. Pharmaceuticals export from India stood at US$ 16.3 billion in FY20. Pharmaceutical export includes bulk drugs, intermediates, drug formulations, biologicals, Ayush and herbal products and surgical. As of October 2020, India exported pharmaceuticals worth US$ 13.87 billion in FY21. Pharmaceutical exports from India stood at US$ 16.28 billion in FY20 and US$ 2.07 billion in October 2020. 

Competitive Strengths: 

  • Large product portfolio with 70+ products. 
  • Strong product manufacturing and development capabilities. 
  • Best quality products, certified by FSSAI and AYUSH department. 

Objectives of the issue         

  • To invest in subsidiaries. 
  • Meet working capital requirements. 
  • Meet general corporate purposes. 
  • Meet issue expenditures. 

Company Financials      

Particulars          31-Mar-20 31-Mar-19 31-Mar-18 
Total Assets          1,317.41 918.09 390.37 
Total Revenue          1,671.27 1,282.27 644.53 
Profit After Tax          12.18 6.88 0.33 

Company Contact Information 

Walpar Nutritions Limited 
2nd Floor, L5: 377 PLOT:5, Opp. Sabarmati, Village 
Taluka kalol, Gandhinagar-382721 
Phone: +91 94277 12047 
Email: finance.walpar@hotmail.com 
Website: http://www.walparnutritions.com/ 


Skyline Financial Services Private Ltd 
Phone: 02228511022 
Email: compliances@skylinerta.com 
Website: https://www.skylinerta.com/ 

Lead Manager(s) 

  1. Beeline Broking Ltd (Past IPO Performance) 

Lead Manager Reports 

  • IPO Lead Manager Performance Summary 
  • IPO Lead Manager Performance Tracker 


Please enter your comment!
Please enter your name here